Medicine
 |
|
3 may 2021 19:27:40 |
| Effectiveness of pirfenidone in idiopathic pulmonary fibrosis according to the autoantibody status: a retrospective cohort study (BMC Pulmonary Medicine) |
|
Tweet Pirfenidone is an anti-fibrotic agent shown to slow the progression of idiopathic pulmonary fibrosis (IPF). However, its effectiveness in association with serological autoimmune features in IPF remains unclear. |
| 188 viewsCategory: Medicine |
 The value of transbronchial lung biopsy in the diagnosis of lymphangioleiomyomatosis (BMC Pulmonary Medicine)Severe COVID-19 in the intensive care unit: a case series (Journal of Medical Case Reports) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
